Genetic and environmental origins of obesity relevant to reproduction

Reproductive BioMedicine Online

Volumn 12, Issue 5, 2006, Pages 526-531

  Franks, Stephen ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Androgens; Anovulation; Candidate genes; Complex trait; Insulin resistance; Polycystic ovarian syndrome (PCOS)

Indexed keywords

ANDROGEN; INSULIN; INSULIN RECEPTOR;

ANOVULATION; ARTICLE; CHROMOSOME 19P; DIET; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENE INTERACTION; GENE MUTATION; GENETIC DISORDER; HEREDITY; HORMONE ACTION; HUMAN; HYPERANDROGENISM; INFERTILITY; INSULIN RELEASE; INSULIN RESISTANCE; LIFESTYLE; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; REPRODUCTION; REPRODUCTIVE HEALTH; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 33646417382     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61177-7     Document Type: Article

References (60)

1. Abbott DH, Foong SC, Barnett DK, Dumesic DA 2004 Nonhuman primates contribute unique understanding to anovulatory infertility in women. Institute of Laboratory Animal Resources Journal 45, 116-131.
2. Abbott DH, Dumesic DA, Franks S 2002 Developmental origin of polycystic ovary syndrome - a hypothesis. Journal of Endocrinology 174, 1-5.
3. Altshuler D, Hirschhorn JN, Klannemark M et al. 2000 The common PPARgamma Pro12A1a polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 26, 76-80.
4. Bellver J, Busso C, Pellicer A et al. 2006 Obesity and ART outcomes. Reproductive BioMedicine Online 12, 570-576.
5. Birch R, Robinson JE, Hardy K, Franks S 2001 Morphological differences in preantral follicle distribution between normal and androgenised ovine ovaries. Endocrine Abstracts 2, P74.
6. Cardon LR, Bell JI 2001 Association study designs for complex diseases. Nature Reviews Genetics 2, 91-99.
7. Carey AH, Chan KL, Short F et al. 1993 Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clinical Endocrinology (Oxford) 38, 653-658.
8. Chadwick J, Mann WN (eds) 1983 Hippocratic Writings; section on Medicine: Airs, Waters, Places (an essay on the influence of climate, water supply and situation on health). Penguin Classics, London, pp. 164-165.
9. Clark AM, Thornley B, Tomlinson L et al. 1998 Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction 13, 1502-1505.
10. Clark AM, Ledger W, Galletly C et al. 1995 Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction 10, 2705-2712.
11. Conway GS, Avey C, Rumsby G 1994 The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome. Human Reproduction 9, 1681-1683.
12. Diamanti-Kandarakis E, Piperi C 2005 Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Human Reproduction Update 11, 631-643.
13. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18, 774-800.
14. Editorial 1999 Freely associating. Nature Genetics 22, 1-2.
15. Ehrmann DA, Schwarz PE, Hara M et al. 2002a Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87, 1669-1673.
16. Ehrmann DA, Tang X, Yoshiuchi I et al. 2002b Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87, 4297-4300.
17. El Mkadem SA, Lautier C, Macari F et al. 2001 Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50, 2164-2168.
18. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL 2005 The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews 26, 251-282.
19. Farooqi IS, O'Rahilly S 2000 Recent advances in the genetics of severe childhood obesity. Archives of Disease in Childhood 83, 31-34.
20. Farooqi IS, Keogh JM, Kamath S et al. 2001 Partial leptin deficiency and human adiposity. Nature 414, 34-35.
21. Franks S 2002 Adult polycystic ovary syndrome begins in childhood. Best Practice and Research. Clinical Endocrinology and Metabolism 16, 263-272.
22. Franks S 1995 Polycystic ovary syndrome. New England Journal of Medicine 333, 853-861.
23. Franks S, McCarthy M 2004 Genetics of ovarian disorders: polycystic ovary syndrome. Reviews in Endocrine and Metabolic Disorders 5, 69-76.
24. Franks S, Gharani N, McCarthy M 2001 Candidate genes in polycystic ovary syndrome. Human Reproduction Update 7, 405-410.
25. Franks S, Gharani N, Waterworth D, et al. 1997 The genetic basis of polycystic ovary syndrome. Human Reproduction 12, 2641-2648.
26. Franks S, Robinson S, Willis DS 1996 Nutrition, insulin and polycystic ovary syndrome. Reviews of Reproduction 1, 47-53.
27. Gilling-Smith C, Willis DS, Beard RW, Franks S 1994 Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 79, 1158-1165.
28. Gloyn AL, Weedon MN, Owen KR et al. 2003 Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568-572.
29. Haddad L, Evans JC, Gharani N et al. 2002 Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87, 2606-2610.
30. Hara M, Alcoser SY, Qaadir A et al. 2002 Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. Journal of Clinical Endocrinology and Metabolism 87, 772-775.
31. Hartz AJ, Barboriak PN, Wong A et al. 1979 The association of obesity with infertility and related menstrual abnormalities in women. International Journal of Obesity 3, 57-73.
32. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K 2002 A comprehensive review of genetic association studies. Genetics in Medicine 4, 45-61.
33. Ibanez L, Potau N, Francois I, de Zegher F 1998 Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. Journal of Clinical Endocrinology and Metabolism 83, 3558-3562.
34. Jackson RS, Creemers JW, Ohagi S et al. 1997 Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nature Genetics 16, 303-306.
35. Kiddy DS, Hamilton-Fairley D, Bush A et al. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clinical Endocrinology (Oxford) 36, 105-111.
36. Kiddy DS, Sharp PS, White DM, Scanlon et al. 1990 Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clinical Endocrinology (Oxford) 32, 213-220.
37. Kopelman PG 1988 Neuroendocrine function in obesity. Clinical Endocrinology (Oxford) 28, 675-689.
38. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES 1996 Parametric and nonparametric linkage analysis: a unified multipoint approach. American Journal of Human Genetics 58, 1347-1363.
39. Laitinen J, Taponen S, Martikainen H et al. 2003 Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. International Journal of Obesity International Journal of Obesity and Related Metabolic Disorders 27, 710-715.
40. Legro RS, Driscoll D, Strauss JF et al. 1998 Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proceedings of the National Academy of Science of the United States of America 95, 14956-14960.
41. Loos RJ, Bouchard C 2003 Obesity - is it a genetic disorder? Journal of Internal Medicine 254, 401-425.
42. Maciel GA, Baracat EC, Benda JA et al. 2004 Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 89, 5321-5327.
43. Montague CT, Farooqi IS, Whitehead JP et al. 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908.
44. Moran L, Bronkworth G, Noakes M, Norman RJ 2006 Effects of lifestyle modification in polycystic ovarian syndrome. Reproductive BioMedicine Online 12, 577-586.
45. Powell BL, Haddad L, Bennett A et al. 2005 Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. Journal of Clinical Endocrinology and Metabolism 90, 2988-2993.
46. Robinson S, Chan SP, Spacey S et al. 1992 Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clinical Endocrinology (Oxford) 36, 537-543.
47. Shalitin S, Phillip M 2003 Role of obesity and leptin in the pubertal process and pubertal growth - a review. International Journal of Obesity International Journal of Obesity and Related Metabolic Disorders 27, 869-874.
48. Spielman RS, Ewens W J 1999 TDT clarification. American Journal of Human Genetics 64, 668.
49. Spielman RS, Ewens WJ 1996 The TDT and other family-based tests for linkage disequilibrium and association. American Journal of Human Genetics 59, 983-989.
50. Talbot JA, Bicknell EJ, Rajkhowa M et al. 1996 Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 81, 1979-1983.
51. Tucci S, Futterweit W, Concepcion ES et al. 2001 Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. Journal of Clinical Endocrinology and Metabolism 86, 446-449.
52. Urbanek M, Woodroffe A, Ewens KG et al. 2005 Candidate gene region for polycystic ovary syndrome (PCOS) on chromosome 19p13.2. Journal of Clinical Endocrinology and Metabolism 90, 6623-6629.
53. Urbanek M, Du Y, Silander K et al. 2003 Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 52, 214-217.
54. Urbanek M, Legro RS, Driscoll DA et al. 1999 Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proceedings of the National Academy of Science of the United States of America 96, 8573-8578.
55. Villuendas G, Escobar-Morreale HF, Tosi F et al. 2003 Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertility and Sterility 79, 219-220.
56. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI 2005 Heritability of polycystic ovary syndrome (PCOS) in a Dutch twin-family study. Journal of Clinical Endocrinology and Metabolism.
57. Waterworth DM, Bennett ST, Gharani N et al. 1997 Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349, 986-990.
58. Webber LJ, Stubbs S, Stark J et al. 2003 Formation and early development of follicles in the polycystic ovary. Lancet 362, 1017-1021.
59. White DM, Polson DW, Kiddy D et al. 1996 Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. Journal of Clinical Endocrinology and Metabolism 81, 3821-3824.
60. Wood JR, Nelson VL, Ho C et al. 2003 The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. Journal of Biological Chemistry 278, 26380-26390.